annual net income:
$426.86M+$259.21M(+154.62%)Summary
- As of today (April 19, 2025), BMRN annual net profit is $426.86 million, with the most recent change of +$259.21 million (+154.62%) on December 31, 2024.
- During the last 3 years, BMRN annual net income has risen by +$490.94 million (+766.13%).
- BMRN annual net income is now -50.02% below its all-time high of $854.03 million, reached on December 31, 2020.
Performance
BMRN Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$124.94M+$18.86M(+17.78%)Summary
- As of today (April 19, 2025), BMRN quarterly net profit is $124.94 million, with the most recent change of +$18.86 million (+17.78%) on December 31, 2024.
- Over the past year, BMRN quarterly net income has stayed the same.
- BMRN quarterly net income is now -84.08% below its all-time high of $784.80 million, reached on September 30, 2020.
Performance
BMRN quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$426.86M+$104.57M(+32.45%)Summary
- As of today (April 19, 2025), BMRN TTM net profit is $426.86 million, with the most recent change of +$104.57 million (+32.45%) on December 31, 2024.
- Over the past year, BMRN TTM net income has stayed the same.
- BMRN TTM net income is now -50.02% below its all-time high of $854.03 million, reached on December 31, 2020.
Performance
BMRN TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BMRN Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +154.6% | 0.0% | 0.0% |
| 3 y3 years | +766.1% | 0.0% | 0.0% |
| 5 y5 years | +1889.9% | 0.0% | 0.0% |
BMRN Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +766.1% | at high | +1978.3% | at high | +984.9% |
| 5 y | 5-year | -50.0% | +766.1% | -84.1% | +315.8% | -50.0% | +766.1% |
| alltime | all time | -50.0% | +167.7% | -84.1% | +129.8% | -50.0% | +167.7% |
BioMarin Pharmaceutical Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $426.86M(+154.6%) | $124.94M(+17.8%) | $426.86M(+32.4%) |
| Sep 2024 | - | $106.08M(-1.0%) | $322.29M(+25.6%) |
| Jun 2024 | - | $107.17M(+20.9%) | $256.59M(+24.9%) |
| Mar 2024 | - | $88.66M(+335.2%) | $205.46M(+22.6%) |
| Dec 2023 | $167.65M(+18.4%) | $20.38M(-49.5%) | $167.65M(+14.0%) |
| Sep 2023 | - | $40.38M(-27.9%) | $147.02M(+47.0%) |
| Jun 2023 | - | $56.04M(+10.2%) | $99.99M(+39.6%) |
| Mar 2023 | - | $50.85M(<-9900.0%) | $71.61M(-49.4%) |
| Dec 2022 | $141.56M(-320.9%) | -$249.00K(-96.3%) | $141.56M(+68.7%) |
| Sep 2022 | - | -$6.65M(-124.0%) | $83.91M(+55.2%) |
| Jun 2022 | - | $27.66M(-77.1%) | $54.07M(+37.4%) |
| Mar 2022 | - | $120.80M(-308.6%) | $39.35M(-161.4%) |
| Dec 2021 | -$64.08M(-107.5%) | -$57.90M(+58.7%) | -$64.08M(-690.8%) |
| Sep 2021 | - | -$36.49M(-382.0%) | $10.85M(-98.7%) |
| Jun 2021 | - | $12.94M(-25.5%) | $832.14M(+5.3%) |
| Mar 2021 | - | $17.37M(+2.0%) | $790.02M(-7.5%) |
| Dec 2020 | $854.03M(-3681.1%) | $17.03M(-97.8%) | $854.03M(+0.2%) |
| Sep 2020 | - | $784.80M(-2789.2%) | $852.02M(+596.9%) |
| Jun 2020 | - | -$29.18M(-135.9%) | $122.26M(+7.2%) |
| Mar 2020 | - | $81.38M(+441.7%) | $114.01M(-578.1%) |
| Dec 2019 | -$23.85M(-69.1%) | $15.02M(-72.7%) | -$23.85M(-43.9%) |
| Sep 2019 | - | $55.04M(-247.0%) | -$42.52M(-61.4%) |
| Jun 2019 | - | -$37.44M(-33.7%) | -$110.18M(+23.1%) |
| Mar 2019 | - | -$56.47M(+1447.2%) | -$89.53M(+16.0%) |
| Dec 2018 | -$77.21M(-34.0%) | -$3.65M(-71.1%) | -$77.21M(-38.2%) |
| Sep 2018 | - | -$12.62M(-24.8%) | -$124.95M(+0.1%) |
| Jun 2018 | - | -$16.79M(-62.0%) | -$124.86M(-13.8%) |
| Mar 2018 | - | -$44.15M(-14.1%) | -$144.90M(+23.8%) |
| Dec 2017 | -$117.04M(-81.4%) | -$51.39M(+310.2%) | -$117.04M(-25.2%) |
| Sep 2017 | - | -$12.53M(-66.0%) | -$156.37M(-13.7%) |
| Jun 2017 | - | -$36.83M(+126.1%) | -$181.27M(-67.8%) |
| Mar 2017 | - | -$16.29M(-82.0%) | -$563.45M(-10.6%) |
| Dec 2016 | -$630.21M(+266.8%) | -$90.72M(+142.4%) | -$630.21M(+33.8%) |
| Sep 2016 | - | -$37.42M(-91.1%) | -$470.87M(-10.2%) |
| Jun 2016 | - | -$419.01M(+404.5%) | -$524.37M(+179.9%) |
| Mar 2016 | - | -$83.05M(-221.0%) | -$187.35M(+9.1%) |
| Dec 2015 | -$171.80M(+28.2%) | $68.62M(-175.5%) | -$171.80M(-44.6%) |
| Sep 2015 | - | -$90.93M(+10.9%) | -$310.21M(+46.4%) |
| Jun 2015 | - | -$81.99M(+21.5%) | -$211.84M(+29.7%) |
| Mar 2015 | - | -$67.50M(-3.3%) | -$163.35M(+21.9%) |
| Dec 2014 | -$133.97M(-24.0%) | -$69.80M(-1037.5%) | -$133.97M(+6.2%) |
| Sep 2014 | - | $7.45M(-122.2%) | -$126.16M(-32.4%) |
| Jun 2014 | - | -$33.50M(-12.1%) | -$186.63M(+6.9%) |
| Mar 2014 | - | -$38.12M(-38.5%) | -$174.66M(-1.0%) |
| Dec 2013 | -$176.35M(+54.2%) | -$61.99M(+16.9%) | -$176.35M(+5.4%) |
| Sep 2013 | - | -$53.02M(+146.2%) | -$167.38M(+39.8%) |
| Jun 2013 | - | -$21.53M(-45.9%) | -$119.71M(-8.0%) |
| Mar 2013 | - | -$39.81M(-24.9%) | -$130.19M(+13.9%) |
| Dec 2012 | -$114.35M(+112.4%) | -$53.01M(+889.6%) | -$114.35M(+29.8%) |
| Sep 2012 | - | -$5.36M(-83.3%) | -$88.07M(-12.3%) |
| Jun 2012 | - | -$32.01M(+33.5%) | -$100.37M(+36.7%) |
| Mar 2012 | - | -$23.97M(-10.3%) | -$73.44M(+36.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$53.84M(-126.2%) | -$26.73M(+51.4%) | -$53.84M(+37.0%) |
| Sep 2011 | - | -$17.65M(+247.7%) | -$39.29M(-120.1%) |
| Jun 2011 | - | -$5.08M(+16.2%) | $195.70M(-2.3%) |
| Mar 2011 | - | -$4.37M(-64.1%) | $200.30M(-2.7%) |
| Dec 2010 | $205.82M(<-9900.0%) | -$12.19M(-105.6%) | $205.82M(-7.6%) |
| Sep 2010 | - | $217.33M(<-9900.0%) | $222.72M(+1752.1%) |
| Jun 2010 | - | -$477.00K(-141.4%) | $12.03M(-13.0%) |
| Mar 2010 | - | $1.15M(-75.6%) | $13.81M(-2924.9%) |
| Dec 2009 | -$488.00K(-101.6%) | $4.71M(-29.1%) | -$489.00K(-102.5%) |
| Sep 2009 | - | $6.64M(+406.1%) | $19.31M(+43.1%) |
| Jun 2009 | - | $1.31M(-110.0%) | $13.49M(-15.6%) |
| Mar 2009 | - | -$13.15M(-153.7%) | $15.99M(-48.1%) |
| Dec 2008 | $30.83M(-295.1%) | $24.51M(+2856.1%) | $30.83M(+246.6%) |
| Sep 2008 | - | $829.00K(-78.2%) | $8.89M(+212.1%) |
| Jun 2008 | - | $3.81M(+126.0%) | $2.85M(-159.1%) |
| Mar 2008 | - | $1.69M(-34.4%) | -$4.82M(-69.5%) |
| Dec 2007 | -$15.80M(-44.6%) | $2.57M(-149.3%) | -$15.80M(-45.1%) |
| Sep 2007 | - | -$5.22M(+35.0%) | -$28.76M(-6.0%) |
| Jun 2007 | - | -$3.86M(-58.4%) | -$30.58M(+9.1%) |
| Mar 2007 | - | -$9.29M(-10.6%) | -$28.05M(-1.7%) |
| Dec 2006 | -$28.53M(-61.6%) | -$10.39M(+47.7%) | -$28.53M(-13.9%) |
| Sep 2006 | - | -$7.04M(+431.0%) | -$33.14M(-20.3%) |
| Jun 2006 | - | -$1.32M(-86.5%) | -$41.58M(-32.5%) |
| Mar 2006 | - | -$9.78M(-34.8%) | -$61.59M(-17.1%) |
| Dec 2005 | -$74.27M(-60.4%) | -$15.00M(-3.1%) | -$74.27M(-47.6%) |
| Sep 2005 | - | -$15.48M(-27.5%) | -$141.70M(-9.0%) |
| Jun 2005 | - | -$21.34M(-5.0%) | -$155.70M(-18.0%) |
| Mar 2005 | - | -$22.46M(-72.8%) | -$189.96M(+1.3%) |
| Dec 2004 | -$187.44M(+147.3%) | -$82.42M(+179.6%) | -$187.44M(+43.4%) |
| Sep 2004 | - | -$29.48M(-47.0%) | -$130.75M(+6.7%) |
| Jun 2004 | - | -$55.60M(+178.8%) | -$122.56M(+61.1%) |
| Mar 2004 | - | -$19.95M(-22.5%) | -$76.06M(+0.3%) |
| Dec 2003 | -$75.80M(-2.1%) | -$25.73M(+20.8%) | -$75.80M(+9.2%) |
| Sep 2003 | - | -$21.29M(+134.0%) | -$69.40M(+6.4%) |
| Jun 2003 | - | -$9.10M(-53.8%) | -$65.22M(-7.5%) |
| Mar 2003 | - | -$19.68M(+1.8%) | -$70.53M(-8.9%) |
| Dec 2002 | -$77.46M(+14.6%) | -$19.33M(+13.0%) | -$77.45M(-16.8%) |
| Sep 2002 | - | -$17.11M(+18.7%) | -$93.05M(+7.0%) |
| Jun 2002 | - | -$14.41M(-45.8%) | -$86.95M(+2.9%) |
| Mar 2002 | - | -$26.60M(-23.8%) | -$84.51M(+25.0%) |
| Dec 2001 | -$67.61M(+80.9%) | -$34.92M(+217.0%) | -$67.61M(+56.9%) |
| Sep 2001 | - | -$11.02M(-8.0%) | -$43.08M(+7.1%) |
| Jun 2001 | - | -$11.97M(+23.4%) | -$40.21M(+13.8%) |
| Mar 2001 | - | -$9.70M(-6.7%) | -$35.33M(-5.4%) |
| Dec 2000 | -$37.36M(+33.1%) | -$10.39M(+27.6%) | -$37.36M(+3.7%) |
| Sep 2000 | - | -$8.15M(+15.0%) | -$36.04M(+1.5%) |
| Jun 2000 | - | -$7.09M(-39.6%) | -$35.49M(+0.8%) |
| Mar 2000 | - | -$11.74M(+29.4%) | -$35.21M(+25.4%) |
| Dec 1999 | -$28.07M(+128.2%) | -$9.07M(+19.4%) | -$28.08M(+47.7%) |
| Sep 1999 | - | -$7.60M(+11.8%) | -$19.01M(+66.6%) |
| Jun 1999 | - | -$6.80M(+47.5%) | -$11.41M(+147.5%) |
| Mar 1999 | - | -$4.61M | -$4.61M |
| Dec 1998 | -$12.30M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual net profit?
- What is the all time high annual net income for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual net income year-on-year change?
- What is BioMarin Pharmaceutical quarterly net profit?
- What is the all time high quarterly net income for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly net income year-on-year change?
- What is BioMarin Pharmaceutical TTM net profit?
- What is the all time high TTM net income for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM net income year-on-year change?
What is BioMarin Pharmaceutical annual net profit?
The current annual net income of BMRN is $426.86M
What is the all time high annual net income for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual net profit is $854.03M
What is BioMarin Pharmaceutical annual net income year-on-year change?
Over the past year, BMRN annual net profit has changed by +$259.21M (+154.62%)
What is BioMarin Pharmaceutical quarterly net profit?
The current quarterly net income of BMRN is $124.94M
What is the all time high quarterly net income for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly net profit is $784.80M
What is BioMarin Pharmaceutical quarterly net income year-on-year change?
Over the past year, BMRN quarterly net profit has changed by $0.00 (0.00%)
What is BioMarin Pharmaceutical TTM net profit?
The current TTM net income of BMRN is $426.86M
What is the all time high TTM net income for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM net profit is $854.03M
What is BioMarin Pharmaceutical TTM net income year-on-year change?
Over the past year, BMRN TTM net profit has changed by $0.00 (0.00%)